Picard Medical, Inc. SEC filings PMI
Picard Medical, Inc. has 140 filings in SEC EDGAR's recent list, going back to Aug 23, 2024. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 19, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| PRE 14A | Preliminary proxy statement | Nov 3, 2026 | Dec 7, 2026 |
| 8-K |
Current report
Officer or director change
|
Nov 3, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 23, 2026 | Oct 20, 2026 |
| S-3 | Shelf registration | Oct 22, 2026 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 13, 2026 | Oct 7, 2026 |
| 8-K |
Current report
New debt, Unregistered share sale
|
Oct 6, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 20, 2026 | Aug 19, 2026 |
| 10-Q | Quarterly report | Aug 19, 2026 | Jun 30, 2026 |
| NT 10-Q | Form nt 10-q | Aug 17, 2026 | Jun 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 7, 2026 | — |
| 8-K |
Current report
Listing notice, Other events
|
Jul 27, 2026 | Jul 22, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Jul 22, 2026 | Jul 21, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jul 21, 2026 | Jul 17, 2026 |
| DEFA14A | Additional proxy material | Jul 16, 2026 | — |
| 8-K/A |
Amended current report
Other events
|
Jul 13, 2026 | Jul 2, 2026 |
| DEFA14A | Additional proxy material | Jul 8, 2026 | — |
| 8-K/A |
Amended current report
Officer or director change
|
Jul 7, 2026 | Jun 23, 2026 |
| 425 | Form 425 | Jul 2, 2026 | — |
| 8-K |
Current report
Other events
|
Jul 2, 2026 | Jul 2, 2026 |
| 425 | Form 425 | Jul 2, 2026 | — |
| 8-K |
Current report
Other events
|
Jul 2, 2026 | Jul 2, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 29, 2026 | Jun 23, 2026 |
| DEF 14A | Proxy statement | Jun 29, 2026 | Jul 17, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 24, 2026 | Jun 18, 2026 |
| PRE 14A | Preliminary proxy statement | Jun 15, 2026 | Jul 17, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jun 5, 2026 | — |
| 144 | Notice of proposed sale | Jun 3, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Jun 2, 2026 | Jun 1, 2026 |
| 144 | Notice of proposed sale | Jun 1, 2026 | — |
| 424B3 | Prospectus | Jun 1, 2026 | — |
| EFFECT | Filing | May 29, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 29, 2026 | May 29, 2026 |
| CORRESP | Letter to the SEC | May 27, 2026 | — |
| UPLOAD | Letter from the SEC | May 26, 2026 | — |
| 8-K |
Current report
Results of operations, Listing notice, Regulation FD disclosure
|
May 21, 2026 | May 15, 2026 |
| S-1 | Registration statement | May 20, 2026 | — |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-K/A | Amended annual report | May 15, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Listing notice
|
May 11, 2026 | May 5, 2026 |
| 424B4 | Prospectus | May 6, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 5, 2026 | May 5, 2026 |
| EFFECT | Filing | May 4, 2026 | — |
| CORRESP | Letter to the SEC | May 4, 2026 | — |
| CORRESP | Letter to the SEC | May 4, 2026 | — |
| S-1/A | Amended registration statement | May 1, 2026 | — |
| CORRESP | Letter to the SEC | Apr 30, 2026 | — |
| CORRESP | Letter to the SEC | Apr 30, 2026 | — |
| CORRESP | Letter to the SEC | Apr 27, 2026 | — |
| CORRESP | Letter to the SEC | Apr 27, 2026 | — |
| S-1 | Registration statement | Apr 27, 2026 | — |
| 8-K |
Current report
Results of operations
|
Apr 22, 2026 | Apr 22, 2026 |
| UPLOAD | Letter from the SEC | Apr 16, 2026 | — |
| DRS | Filing | Apr 14, 2026 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Change to shareholder rights
|
Apr 13, 2026 | Apr 7, 2026 |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 27, 2026 | Mar 25, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2026 | Mar 25, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 20, 2026 | Mar 20, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 19, 2026 | Mar 19, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 17, 2026 | Mar 17, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Mar 16, 2026 | Mar 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2026 | Mar 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 2, 2026 | Mar 2, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 26, 2026 | Feb 26, 2026 |
| DEFR14A | Filing | Feb 19, 2026 | — |
| DEF 14A | Proxy statement | Feb 19, 2026 | Mar 10, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 11, 2026 | — |
| PRE 14A | Preliminary proxy statement | Feb 10, 2026 | Feb 10, 2026 |
| 424B3 | Prospectus | Feb 10, 2026 | — |
| EFFECT | Filing | Feb 6, 2026 | — |
| CORRESP | Letter to the SEC | Feb 4, 2026 | — |
| S-1/A | Amended registration statement | Feb 4, 2026 | — |
| S-8 | Employee stock plan registration | Jan 27, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 27, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2026 | Jan 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2026 | Jan 13, 2026 |
| S-1 | Registration statement | Jan 12, 2026 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Dec 30, 2025 | Dec 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 18, 2025 | Dec 18, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 9, 2025 | Dec 9, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 4, 2025 | Dec 4, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 3, 2025 | Dec 3, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Nov 26, 2025 | Nov 26, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 26, 2025 | Nov 26, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 19, 2025 | Nov 19, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2025 | Nov 14, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 3 | Initial insider ownership | Nov 13, 2025 | Aug 11, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 13, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 27, 2025 | Oct 24, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Oct 14, 2025 | Oct 10, 2025 |
| DEF 14A | Proxy statement | Sep 29, 2025 | Oct 10, 2025 |
| PRE 14A | Preliminary proxy statement | Sep 18, 2025 | Sep 18, 2025 |
| 10-Q | Quarterly report | Sep 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Other events
|
Sep 10, 2025 | Sep 9, 2025 |
| 8-K |
Current report
Material agreement, Officer or director change, Bylaw or fiscal year change, Other events
|
Sep 4, 2025 | Aug 28, 2025 |
| 424B4 | Prospectus | Sep 2, 2025 | — |
| 3/A | Form 3/a | Aug 28, 2025 | Aug 28, 2025 |
| 3/A | Form 3/a | Aug 28, 2025 | Aug 28, 2025 |
| 3/A | Form 3/a | Aug 28, 2025 | Aug 28, 2025 |
| 3 | Initial insider ownership | Aug 28, 2025 | Aug 28, 2025 |
| 3 | Initial insider ownership | Aug 28, 2025 | Aug 28, 2025 |
| 3 | Initial insider ownership | Aug 28, 2025 | Aug 28, 2025 |
| 3 | Initial insider ownership | Aug 28, 2025 | Aug 28, 2025 |
| 3 | Initial insider ownership | Aug 28, 2025 | Aug 28, 2025 |
| 3 | Initial insider ownership | Aug 28, 2025 | Aug 28, 2025 |
| CERT | Nyse american certification | Aug 28, 2025 | — |
| EFFECT | Filing | Aug 12, 2025 | — |
| 8-A12B | Filing | Aug 11, 2025 | — |
| CORRESP | Letter to the SEC | Aug 8, 2025 | — |
| CORRESP | Letter to the SEC | Aug 8, 2025 | — |
| S-1/A | Amended registration statement | Aug 6, 2025 | — |
| FWP | Free writing prospectus | Jul 30, 2025 | — |
| CORRESP | Letter to the SEC | Jul 30, 2025 | — |
| S-1/A | Amended registration statement | Jul 30, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 25, 2025 | — |
| FWP | Free writing prospectus | Jul 18, 2025 | — |
| S-1/A | Amended registration statement | Jul 18, 2025 | — |
| S-1/A | Amended registration statement | Jul 14, 2025 | — |
| S-1/A | Amended registration statement | May 23, 2025 | — |
| CORRESP | Letter to the SEC | May 23, 2025 | — |
| UPLOAD | Letter from the SEC | May 19, 2025 | — |
| S-1/A | Amended registration statement | May 9, 2025 | — |
| CORRESP | Letter to the SEC | May 9, 2025 | — |
| UPLOAD | Letter from the SEC | May 5, 2025 | — |
| S-1/A | Amended registration statement | Apr 25, 2025 | — |
| CORRESP | Letter to the SEC | Apr 24, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 14, 2025 | — |
| S-1 | Registration statement | Apr 1, 2025 | — |
| CORRESP | Letter to the SEC | Mar 31, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 7, 2025 | — |
| DRS/A | Filing | Jan 24, 2025 | — |
| CORRESP | Letter to the SEC | Jan 23, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 14, 2025 | — |
| CORRESP | Letter to the SEC | Dec 26, 2024 | — |
| DRS/A | Filing | Dec 26, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 10, 2024 | — |
| DRS/A | Filing | Nov 12, 2024 | — |
| DRS | Filing | Aug 23, 2024 | — |
Showing 140 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- PMI (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Tucson, AZ
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2030617
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.